Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study performs standardized testing of tumor tissue samples to learn which genes are mutated (have changed) in order to provide personalized cancer therapy options to cancer patients at MD Anderson. This may help doctors use testing information on tumors to identify clinical trials that may be most relevant to patients. Researchers may also use the information learned from this study to develop a database of the different kinds of mutations in cancer-related genes.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony nowotwór (glejak, mięsak, czerniak lub chłoniak/białaczka) lub podejrzenie takiego nowotworu
- •Zdolność do zrozumienia informacji o badaniu i chęć podpisania zgody
- •Dostępna próbka tkanki guza do badania (archiwalna lub pobrana podczas operacji)
- •Możliwość testowania na komórkach wolnych DNA we krwi (dla wybranych pacjentów)
Simplified criteria — AI translation
Trial details
- Last updated (source)
- August 21, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
M D Anderson Cancer Center
Houston, United States
Trial contact
Funda Meric-Bernstam, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/22/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.